Wolverine 10mg (BPC-157 + TB-500).
A little more context.

Start with the source.

Equal-mass BPC-157 and TB-500 co-formulation marketed for recovery and tissue-repair research.

Its association with recovery is a topic classification, not a claim of proven benefit. Research may involve laboratory models, animal studies, or selected clinical populations. Those findings do not automatically apply to an individual.

Questions worth bringing.

• What type of research supports this topic, and what are its limitations?
• Does the study evaluate this exact compound and formulation?
• What established options are appropriate for my situation?
• What should I track, and who should review it?